On October 1, 2019 Cellular Biomedicine Group Inc. (NASDAQ: CBMG) ("CBMG" or the "Company"), a biopharmaceutical firm engaged in the drug development of immunotherapies for cancer and stem cell therapies for degenerative diseases, reported that Derrick Li, Head of Strategy for the Company, will present at Cantor Fitzgerald’s 2019 Global Healthcare Conference to be held at the InterContinental New York Barclay Hotel in New York, NY on Thursday, October 3, 2019 at 3:00pm ET (Press release, Cellular Biomedicine Group, OCT 1, 2019, View Source [SID1234539997]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

For more information about the conference, or to schedule a one-on-one meeting with CBMG management, please contact KCSA Strategic Communications at [email protected], your Cantor representative directly, or send an email to [email protected].